Microalbuminuria, Impaired Glucose Tolerance, and Their Prognostic Implications in Patients With Chronic Heart Failure: Insights From the SUPPlemental Benefit of an Angiotensin Receptor Blocker in Hypertensive Patients With Stable Heart Failure Using OlmesaRTan (SUPPORT) Trial

被引：0
|
作者：
Nochioka, Kotaro
Sakata, Yasuhiko
Oikawa, Takuya
Abe, Ruri
Kasahara, Shintaro
Sato, Masayuki
Aoyanagi, Hajime
Shiroto, Takashi
Takahashi, Jun
Miyata, Satoshi
Shimokawa, Hiroaki
机构：
来源：
CIRCULATION | 2017年 / 136卷
关键词：
Heart failure; Insulin resistance; Diabetes Mellitus; Kidney;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
14748
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Prognostic Impact of Metabolic Syndrome in Patients With Chronic Heart Failure: Data From Gissi-Hf Trial
    Savarese, Gianluigi
    Perrone-Filardi, Pasquale
    Scarano, Marco
    Cavazzina, Riccardo
    Trimarco, Bruno
    Minneci, Sergio
    Maggioni, Aldo Pietro
    Tavazzi, Luigi
    Tognoni, Gianni
    Marchioli, Roberto
    CIRCULATION, 2013, 128 (22)
  • [22] Efficacy and tolerability of adding an angiotensin receptor blocker in patients with heart failure already receiving an angiotensin-converting inhibitor plus aldosterone antagonist, with or without a beta blocker. Findings from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial
    Weir, R. A. P.
    McMurray, John J. V.
    Puu, Margareta
    Solomon, Scott D.
    Olofsson, Bertil
    Granger, Christopher B.
    Yusuf, Salim
    Michelson, Eric L.
    Swedberg, Karl
    Pfeffer, Marc A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2008, 10 (02) : 157 - 163
  • [23] The predictive value of stable precursor fragments of vasoactive peptides in patients with chronic heart failure: data from the GISSI-heart failure (GISSI-HF) trial
    Masson, Serge
    Latini, Roberto
    Carbonieri, Emanuele
    Moretti, Luciano
    Rossi, Maria Grazia
    Ciricugno, Santo
    Milani, Valentina
    Marchioli, Roberto
    Struck, Joachim
    Bergmann, Andreas
    Maggioni, Aldo P.
    Tognoni, Gianni
    Tavazzi, Luigi
    EUROPEAN JOURNAL OF HEART FAILURE, 2010, 12 (04) : 338 - 347
  • [24] Prognostic Impact of Pulmonary Artery Pulsatility Index (PAPi) in Patients With Advanced Heart Failure: Insights From the ESCAPE Trial
    Kochav, Stephanie Meller
    Flores, Raul J.
    Truby, Lauren K.
    Topkara, Veli K.
    JOURNAL OF CARDIAC FAILURE, 2018, 24 (07) : 453 - 459
  • [25] Transition from angiotensin-converting enzyme inhibitor/angiotensin-II-receptor-blocker to sacubitril/valsartan in chronic heart failure patients: Initial experiences in clinical practice
    Hlavata, Katerina
    Hoskova, Lenka
    Franekova, Janka
    Jabor, Antonin
    Kautzner, Josef
    Melenovsky, Vojtech
    Benes, Jan
    COR ET VASA, 2018, 60 (03) : E209 - E214
  • [26] Prognostic value of blood urea nitrogen in patients hospitalized with worsening heart failure: Insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) study
    Filippatos, Gerasimos
    Rossi, Joseph
    Lloyd-Jones, Donald M.
    Stough, Wendy Gattis
    Ouyang, John
    Shin, David D.
    O'Connor, Christopher
    Adams, Kirkwood F.
    Orlandi, Cesare
    Gheorghiade, Mihai
    JOURNAL OF CARDIAC FAILURE, 2007, 13 (05) : 360 - 364
  • [27] Marked suppression of renin levels by β-receptor blocker in patients treated with standard heart failure therapy:: a potential mechanism of benefit from β-blockade
    Holmer, SR
    Hengstenberg, C
    Mayer, B
    Engel, S
    Löwel, H
    Riegger, GAJ
    Schunkert, H
    JOURNAL OF INTERNAL MEDICINE, 2001, 249 (02) : 167 - 172
  • [28] Prognostic impact of 6 min walk test distance in patients with systolic heart failure: insights from the WARCEF trial
    Matsumoto, Kenji
    Xiao, Yi
    Homma, Shunichi
    Thompson, John L. P.
    Buchsbaum, Richard
    Ito, Kazato
    Anker, Stefan D.
    Qian, Min
    Di Tullio, Marco R.
    ESC HEART FAILURE, 2021, 8 (02): : 819 - 828
  • [29] Impaired left ventricular global longitudinal strain in patients with heart failure with preserved ejection fraction: insights from the RELAX trial
    DeVore, Adam D.
    McNulty, Steven
    Alenezi, Fawaz
    Ersboll, Mads
    Vader, Justin M.
    Oh, Jae K.
    Lin, Grace
    Redfield, Margaret M.
    Lewis, Gregory
    Semigran, Marc J.
    Anstrom, Kevin J.
    Hernandez, Adrian F.
    Velazquez, Eric J.
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 (07) : 893 - 900
  • [30] Synergistic Effect of Combined HMG-CoA Reductase Inhibitor and Angiotensin-II Receptor Blocker Therapy in Patients With Chronic Heart Failure - The HF-COSTAR Trial
    Maejima, Yasuhiro
    Nobori, Kiyoshi
    Ono, Yuichi
    Adachi, Susumu
    Suzuki, Jun-ichi
    Hirao, Kenzo
    Isobe, Mitsuaki
    Ito, Hiroshi
    CIRCULATION JOURNAL, 2011, 75 (03) : 589 - 595
12345